Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alfacalcidol in postmenopausal Chinese women with osteoporosis or osteopenia
ChiCTR-ONC-11001508Phase 4Completed
- Sponsor
- Peking Union Medical College Hospital
- Start
- Jan 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of alfacalcidol in osteoporosis and osteopenia, sponsored by Peking Union Medical College Hospital. Primary endpoints: Bone mineral density, 1,25-dihydroxyvitamin D3 and 4 more. Started Jan 2011; status: completed.
02
Drugs
alfacalcidol
03
Conditions
osteoporosisosteopenia
Beyond the preview
Go deeper on ChiCTR-ONC-11001508.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-ONC-11001508.